Literature DB >> 9107306

Immunochemical approach to the mapping of an assembled epitope of human chorionic gonadotropin: proximity of CTP-alpha to the receptor binding region of the beta-subunit.

N Venkatesh1, G S Murthy.   

Abstract

A single-step solid-phase RIA (SS-SPRIA) developed in our laboratory using hybridoma culture supernatants has been utilised for the quantitation of epitope-paratope interactions. Using SS-SPRIA as a quantitative tool for the assessment of epitope stability, it was found that several assembled epitopes of human chorionic gonadotropin (hCG) are differentially stable to proteolysis and chemical modification. Based on these observations an approach has been developed for identifying the amino acid residues constituting an epitopic region. This approach has now been used to map an assembled epitope at/near the receptor binding region of the hormone. The mapped site forms a part of the seat belt region and the cystine knot region (C34-C38-C88-C90-H106). The carboxy terminal region of the alpha-subunit forms a part of the epitope indicating its proximity to the receptor binding region. These results are in agreement with the reported receptor binding region identified through other approaches and the X-ray crystal structure of hCG.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107306     DOI: 10.1016/s0022-1759(96)00246-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Analysis of human chorionic gonadotropin-monoclonal antibody interaction in BIAcore.

Authors:  Banerjee Ashish; Gundlupet Satyanarayana Murthy
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

2.  Epitope mapping from real time kinetic studies - role of crosslinked disulphides and incidental interacting regions in affinity measurements: study with human chorionic gonadotropin and monoclonal antibodies.

Authors:  Nonavinakere Seetharam Srilatha; P Tamil Selvi; Gundlupet Satyanarayana Murthy
Journal:  J Biosci       Date:  2005-06       Impact factor: 1.826

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.